Testing Latest Version of NidekRS3000Adv

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-02-01

Study Completion Date

2018-03-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whether these changes are useful in the diagnosis and treatment of eye diseases. Using images of previous participants will allow us to demonstrate the advancement of different technologies, as well be used to allow comparisons between current technologies.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Measuring Geographic Atrophy in AMD Patients Using the Nidek MP-3 Microperimetry Device

NCT02445313

Age-related Macular Degeneration (AMD)

COMPLETED

Nidek RS3000 Comparative Study

NCT01384487

Glaucoma Retinal Disease Corneal Disease

COMPLETED

Novel Glaucoma Diagnostics

NCT00286637

Glaucoma Macular Disease

RECRUITING

oCular Examination at Cell RESolution With Optical TransmissionTomography

NCT06976034

Glaucoma Associated With Other Ocular Disorders

RECRUITING NA

Data Collection Study of the Nidek Optical Coherence Tomography RS-3000 for 3D Measurements of the Eye

NCT01663688

Ocular Physiology

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glaucoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

RS3000Adv

Nidek RS3000Adv device to be used to take images which will allow measurement of vascularization in participants

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy participants
* 18 years old or older

Exclusion Criteria

* Those suffering from head, neck or other injury which makes them unable to position themselves in head restraint for imaging
* subjects who are unable to maintain retinal fixation on a specified target
* subjects unable to achieve sufficient pupil dilation and alignment stability for imaging to take place
* subjects with media opacity which preclude high quality imaging will be excluded.
* vulnerable subjects
* subjects under 18
* pregnant subjects
* economically and educationally disadvantaged subjects
* decision impaired subjects
* homeless subjects

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes